Galazolin, 0.05% drops 10 ml

Name: Galazolin, 0.05% drops 10 ml
SKU: 110291
Availability: InStock

€1.13

EAN: 5900257035013 SKU: 110291 Categories: ENT Organs, Medicine, Runny nose

Description

A vasoconstrictor for local use in ENT practice. Alpha-adrenomimetic of the group of imidazole derivatives. In low concentrations it acts on α2-adrenoreceptors, in high concentrations it acts on α1-adrenoreceptors.

In local application causes constriction of blood vessels, which leads to reduction of edema and hyperemia of mucous membranes of the nasopharynx, reduces nasal discharge, facilitates nasal breathing in rhinitis.

The action of the drug starts within 5-10 min and lasts for 5-6 h when used in the form of nasal drops and for 10 h when used in the form of nasal gel.

Indications

Nasal congestion, Pollinosis, Allergies, Otitis, Runny nose (rhinitis), Sinusitis

acute rhinitis of viral or bacterial genesis;
allergic rhinitis;
acute sinusitis;

chronic sinusitis in aggravation phase;
pollenosis
median otitis (in order to decrease nasopharyngeal mucous membrane edema and restore Eustachian tube patency).

Active ingredient

Xylometazoline

Composition

1 ml of drops contains:

Active ingredient:

xylometazoline hydrochloride;

Associates:

sodium hydrophosphate dodecahydrate,

sodium dihydrophosphate monohydrate,

sodium chloride, <

dinatate edetate

benzalkonium chloride 50%,

sorbitol,

purified water – up to 1 ml.

How to take, the dosage
How to take, the dosage
Galazolin in the form of 0.05% drops is indicated for children from 2 to 6 years of age, 1 to 2 drops in each nostril 1-2 times a day.
Galazolin in the form of nasal drops should not be used more than 3 times a day.

Special Instructions
Special Instructions
Long-term use of Galazolin leads to weakening of its action, development of nasal mucosal atrophy and reactive hyperemia with medicated rhinitis.

Contraindications
Contraindications
high sensitivity to the components of the drug;
atrophic rhinitis;
closed-angle glaucoma;
Airlines with hypertension;
tachycardia.arterial hypertension;
expressed atherosclerosis;
tachycardia;
hyperthyroidism (for nasal drops);
cerebral membrane surgery (history);
Concurrent use of MAO inhibitors and a period of 14 days after the end of their use;
concurrent use of tricyclic antidepressants;
pregnancy;
children under 6 years of age (for 0.1% nasal drops) and under 2 years of age (for 0.05% nasal drops);
children under 12 years of age (for 0.1% nasal gel) and under 3 years of age (for 0.05% nasal gel).
With caution when using the drug during lactation, in diabetes, in angina III-IV functional class, prostatic hyperplasia, pheochromocytoma (for nasal drops), hyperthyroidism (for nasal gel).
.

Side effects
Side effects
Local reactions: sometimes – burning, dry nasal mucosa, sneezing; rarely – reactive hyperemia (a strongly pronounced feeling of nasal congestion after the effect of the drug passes).
Others: sometimes in local overdose – tachycardia, increased BP; very rarely – anxiety, insomnia, fatigue, headache, nausea.
.

Pregnancy use
Pregnancy use
Galazolin should be used only after assessing the risk-benefit ratio for the fetus and the mother.
The recommended doses should not be exceeded in pregnancy and during lactation (breastfeeding).

Similarities
Similarities
Atrivin, Galazolin, Xylen, Snoop, Rinonorm, Ximeline Eco, Rinorus, Rinostop, Rinomaris, Xylometazoline, Tisin Classic, Ximeline Eco Menthol, Asterisk, Xyloct, Cold and Flu, Asterisk for Colds, Quatran xylo

Additional information
Weight 0.020 kg
Shelf life
3 years
Conditions of storage
The drug should be stored in the dark place out of the reach of children at 15 ° to 25 ° C.
Manufacturer
Polfa Warsaw Pharmaceutical Plant, Poland
Medication form
nasal drops
Brand
Polfa Warsaw Pharmaceutical Plant